Grant: CIHR Fellowship
Direct Payment
$150,000.00
Nov (CCN3) regulation of hematopoietic stem cells
FY 2008-09
Summary
Hematopoietic stem cells (HSCs) are very rare cells that are found in the bone marrow of adults and in umbilical cord blood that act to maintain an individual's blood and immune system throughout their life. HSCs divide following stress or injury, such as disease or blood loss, to help restore balance to the blood system. When necessary, HSCs divide; producing at least one identical copy of themselves to maintain the HSC population in addition to replenishing depleted blood cells in the case of blood loss, or increasing the number of blood cells in the case of infection. The signals in the body that cause HSCs to divide in this fashion are currently unknown. Certain diseases, such as leukemia, require that the blood system be replaced by means of a bone marrow transplant. The bone marrow, and the HSCs within it, comes from a donor therefore there is a chance of transplant failure. Banking and using one's own HSC-rich cord blood would avoid donor transplant failure, unfortunately, there are not enough HSCs in an individual's cord blood to be used for transplantation and we currently do not have the ability to expand HSCs outside of the body. The ability to culture and expand these rare HSCs would allow for transplantation of an individual's cells and would replace the current need for donor bone marrow, which is difficult and painful to obtain. A protein called Nov was recently shown to expand HSCs in culture without causing them to loose their ability to reestablish the entire blood system. It is unclear, however, how or what Nov is doing to cause this expansion of HSCs. We will determine how Nov is affecting HSCs. This will be done initially outside of the body in tissue culture and eventually using animal models. If we can understand how Nov causes HSC expansion, we could directly and positively impact the expansion of cord blood HSCs for use in transplants and anti-leukemia therapies.
Department
Program
CIHR Fellowship
Recipient
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
173591
Name
Stewart Morag H
Country
United Kingdom
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Nov (CCN3) regulation of hematopoietic stem cells
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cell Sorting; Cellular Interactions; Differentiation; Extrinsic Regulation; Human Hematopoietic Stem Cells; Leukemia; Receptors; Self-Renewal; Signaling; Transplantation
Abstract
Hematopoietic stem cells (HSCs) are very rare cells that are found in the bone marrow of adults and in umbilical cord blood that act to maintain an individual's blood and immune system throughout their life. HSCs divide following stress or injury, such as disease or blood loss, to help restore balance to the blood system. When necessary, HSCs divide; producing at least one identical copy of themselves to maintain the HSC population in addition to replenishing depleted blood cells in the case of blood loss, or increasing the number of blood cells in the case of infection. The signals in the body that cause HSCs to divide in this fashion are currently unknown. Certain diseases, such as leukemia, require that the blood system be replaced by means of a bone marrow transplant. The bone marrow, and the HSCs within it, comes from a donor therefore there is a chance of transplant failure. Banking and using one's own HSC-rich cord blood would avoid donor transplant failure, unfortunately, there are not enough HSCs in an individual's cord blood to be used for transplantation and we currently do not have the ability to expand HSCs outside of the body. The ability to culture and expand these rare HSCs would allow for transplantation of an individual's cells and would replace the current need for donor bone marrow, which is difficult and painful to obtain. A protein called Nov was recently shown to expand HSCs in culture without causing them to loose their ability to reestablish the entire blood system. It is unclear, however, how or what Nov is doing to cause this expansion of HSCs. We will determine how Nov is affecting HSCs. This will be done initially outside of the body in tissue culture and eventually using animal models. If we can understand how Nov causes HSC expansion, we could directly and positively impact the expansion of cord blood HSCs for use in transplants and anti-leukemia therapies.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Stewart, Morag H
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~